March 2023
Alvergne A et al. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience. 2023 Mar 15. DOI:https://doi.org/10.1016/j.isci.2023.106401
Full text
Barateaux V et al. Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination. 2023 Mar 15. Science Tranlational Medicine. 2023 Mar 15. https://doi.org/10.1126/scitranslmed.ade0550
Full text
Bramante C et al. Outpatient Treatment of COVID-19 and the Development of Long COVID Over 10 Months: A Multi-Center, Quadruple-Blind, Parallel Group Randomized Phase 3 Trial. Lancet Pre-print. Available at SSRN: https://ssrn.com/abstract=4375620 or http://dx.doi.org/10.2139/ssrn.4375620
Full text
Byambasuren O et al. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385
Full text
Bennet C M. Covid-19 in Australia: How did a country that fought so hard for extra time end up so ill prepared? BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p469
Full text
Calvert C. et al. Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries. Nat Hum Behav (2023). https://doi.org/10.1038/s41562-023-01522-y
Abstract
Cheung M W et al. Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients. medRxiv 2023.03.01.23286513; doi: https://doi.org/10.1101/2023.03.01.23286513
Full text
Deo R et al. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Annals of Int Med. 2023 Mar. https://doi.org/10.7326/M22-2381
Full text
DeVries A et al. One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database. JAMA Health Forum. 2023;4(3):e230010. doi:10.1001/jamahealthforum.2023.0010
Full text
Edlow AG et al. Sex-Specific Neurodevelopmental Outcomes Among Offspring of Mothers With SARS-CoV-2 Infection During Pregnancy. JAMA Netw Open. 2023;6(3):e234415. doi:10.1001/jamanetworkopen.2023.4415
Full text
Fai E Y et al. Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19. Annals of Int Med. 2023 March 14. Doi: https://doi.org/10.7326/M22-3057
Full text
Fang MC et al. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023;6(3):e232338. doi:10.1001/jamanetworkopen.2023.2338
Full text
Gao F et al Robust T cell responses to Pfizer/BioNTech vaccine compared to infection and evidence of attenuated peripheral CD8+ T cell responses due to COVID-19. Immunity. 2023 Mar 15. DOI:https://doi.org/10.1016/j.immuni.2023.03.005
Full text
Gilbert G L. Aged care residents — and everybody else — would benefit from better control of COVID‐19 transmission. Med J Aust 2023; 218 (4): 166-167. || doi: 10.5694/mja2.51843
Full text
Goligher EC et al. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19. JAMA. Published online March 21, 2023. doi:10.1001/jama.2023.3651
Full text
Harris E. Nasally Administered Monoclonal Antibody for COVID-19. JAMA. Published online March 22, 2023. doi:10.1001/jama.2023.4000
Full text
Heine J et al. Structural brain changes in patients with post-COVID fatigue: a prospective observational study. eClinical Med. 2023 February 27. DOI:https://doi.org/10.1016/j.eclinm.2023.101874
Full text
Jang EJ et al. Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection. JAMA Netw Open. 2023;6(3):e232578. doi:10.1001/jamanetworkopen.2023.2578
Full text
Koirala A et al. Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet. 2023 March 22. DOI:https://doi.org/10.1016/j.lanwpc.2023.100736
Full text
Labbé V et al. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial. JAMA Intern Med. Published online March 22, 2023. doi:10.1001/jamainternmed.2023.0456
Full text
Maia I S et al. Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial. The Lancet. 2023 March 07. DOI:https://doi.org/10.1016/j.lana.2023.100466
Full text
McGarry B E et al. Covid-19 Surveillance Testing and Resident Outcomes in Nursing Homes. NEJM. 2023 March 23. DOI: 10.1056/NEJMoa2210063
Full text
O’Brien WJ et al. Estimated Risk of Adverse Surgical Outcomes Among Patients With Recent COVID-19 Infection Using Target Trial Emulation Methods. JAMA Netw Open. 2023;6(3):e234876. doi:10.1001/jamanetworkopen.2023.4876
Full text
Ockene MW et al. Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure, The Journal of Clinical Endocrinology & Metabolism, 2023;, dgad130, https://doi.org/10.1210/clinem/dgad130
Full text
Schweizer S et al. COVID-19 Risks Across the Lifespan (CORAL) Consortium. Association of Antenatal COVID-19–Related Stress With Postpartum Maternal Mental Health and Negative Affectivity in Infants. JAMA Netw Open. 2023;6(3):e232969. doi:10.1001/jamanetworkopen.2023.2969
Full text
Spiegel K et al. A meta-analysis of the associations between insufficient sleep duration and antibody response to vaccination. Current Biology. 2023 Mar 13. DOI:https://doi.org/10.1016/j.cub.2023.02.017
Full text
Sumner MW et al. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. JAMA Netw Open. 2023;6(3):e232328. doi:10.1001/jamanetworkopen.2023.2328
Full text https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802161
Full text
Sun Y et al. Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts BMJ 2023; 380 :e074224 doi:10.1136/bmj-2022-074224
Full text
Tanne J H. Covid-19: US studies show racial and ethnic disparities in long covid BMJ 2023 March 06. doi: https://doi.org/10.1136/bmj.p535
Full text
The Lancet. Long COVID: 3 years in. The Lancet. 2023 March 23. DOI:https://doi.org/10.1016/S0140-6736(23)00493-2
Full text
Tsampasian V et al. Risk Factors Associated With Post−COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0750
Full text
Wang Y et al. Sarcopenia and COVID-19 Outcomes. Clin Interv Aging. 2023 Mar 9;18:359-373. doi: 10.2147/CIA.S398386. PMID: 36923269; PMCID: PMC10010141.
Full text
Wang H et al. Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data. The Lancet. 2023 Feb 27. DOI:https://doi.org/10.1016/j.lanwpc.2023.100716
Full text
Xie Y et al. Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records BMJ 2023; 380 :e072705 doi:10.1136/bmj-2022-072705
Full text
Xie Y et al. Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition. JAMA Intern Med. Published online March 23, 2023. doi:10.1001/jamainternmed.2023.0743
Full text
Xu, E et al. Long-term gastrointestinal outcomes of COVID-19. Nat Commun 14, 983 (2023). https://doi.org/10.1038/s41467-023-36223-7
Full text
Zhang XJ et al. Prevalence of Myopia in Children Before, During, and After COVID-19 Restrictions in Hong Kong. JAMA Netw Open. 2023;6(3):e234080. doi:10.1001/jamanetworkopen.2023.4080
Full text
February 2023
Aggarwal N et al. Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study. The Lancet. 2023 Feb10. DOI:https://doi.org/10.1016/S1473-3099(23)00011-7
Full text
Burgess T et al. Key ethical issues encountered during COVID-19 research: a thematic analysis of perspectives from South African research ethics committees. BMC Med Ethics 24, 11 (2023). https://doi.org/10.1186/s12910-023-00888-y
Full text
Callaway E et al. COVID drug drives viral mutations — and now some want to halt its use. 2023 Feb 7. Nature 614, 399 (2023) doi: https://doi.org/10.1038/d41586-023-00347-z
Full text
Chourpiliadis C et al. (2023) Short-term improvement of mental health after a COVID-19 vaccination. PLoS ONE 18(2): e0280587. https://doi.org/10.1371/journal.pone.0280587
Full text
COVID-19 Forecasting team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. The Lancet. 2023 Feb 16. DOI:https://doi.org/10.1016/S0140-6736(22)02465-5
Full text
Dagher H et al. (2023) Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. eLife 12:e81182. https://doi.org/10.7554/eLife.81182
Full text
Dennis A et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. Journal of the Royal Society of Medicine. 2023;0(0). doi:10.1177/01410768231154703
Full text
Dowse G et al. Born into an isolating world: family-centred care for babies born to mothers with COVID-19. eClinicalMedicine. 2023 Feb 21. DOI:https://doi.org/10.1016/j.eclinm.2022.101822
Full text
Frasca L et al. Safety of COVID-19 vaccines in patients with autoimmune diseases, in patients with cardiac issues, and in the healthy population. Pathogens. 2023; 12(2):233. https://doi.org/10.3390/pathogens12020233
Full text
Huang S et al. China's COVID-19 reopening measures—warriors and weapons. The Lancet. 2023 Feb 25. DOI:https://doi.org/10.1016/S0140-6736(23)00213-1
Full text
Huang, P et al. Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener 12, 5 (2023). https://doi.org/10.1186/s40035-023-00337-1
Full text
Jefferson T et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database of Systematic Reviews 2023, Issue 1. Art. No.: CD006207. DOI: 10.1002/14651858.CD006207.pub6. Accessed 26 February 2023.
Full text
Jorgensen S et al. Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study. BMJ 2023 Feb 8. doi: https://doi.org/10.1136/bmj-2022-074035
Full text
Kiang MV et al. Excess mortality among US physicians during the COVID-19 pandemic. JAMA Intern Med. Published online February 06, 2023. doi:10.1001/jamainternmed.2022.6308
Full text
Kwan AC et al. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw Open. 2023;6(2):e2255965. doi:10.1001/jamanetworkopen.2022.55965
Full text
Kwok, W.C et al. Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respir Res 24, 53 (2023). https://doi.org/10.1186/s12931-023-02363-z
Full text
Lai CC et al. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect. 2023 Feb;56(1):1-9. doi: 10.1016/j.jmii.2022.10.003. Epub 2022 Oct 15. PMID: 36283919; PMCID: PMC9576029.
Full text
Lai F et al. Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study. CMAJ Jan 2023, 195 (4) E143-E152; DOI: 10.1503/cmaj.221068
Full text
Langford B et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. The Lancet Micobiome. 2023 Jan 31. DOI:https://doi.org/10.1016/S2666-5247(22)00355-X
Full text
Morawska L et al. COVID-19 and airborne transmission: Science rejected, lives lost. Can society do better?, Clinical Infectious Diseases, 2023;, ciad068, https://doi.org/10.1093/cid/ciad068
Full text
Munoz FM et al. Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age. N Engl J Med 2023; 388:621-634 DOI: 10.1056/NEJMoa2211031
Full text
Murakami M et al Sensitivity of rapid antigen tests for COVID-19 during the Omicron variant outbreak among players and staff members of the Japan Professional Football League and clubs: a retrospective observational study. BMJ Open 2023;13:e067591. doi: 10.1136/bmjopen-2022-067591
Full text
Naggie S et al. Effect of higher-dose ivermectin for 6 Days vs placebo on time to sustained recovery in outpatients with COVID-19: A randomized clinical trial. JAMA. Published online February 20, 2023. doi:10.1001/jama.2023.1650
Full text
Pan Y et al. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. The Lancet. 2023 Feb 8. DOI:https://doi.org/10.1016/S0140-6736(23)00129-0
Full text
Portmann L et al. Hospital outcomes of community-acquired SARS-CoV-2 omicron variant infection compared with influenza infection in Switzerland. JAMA Netw Open. 2023;6(2):e2255599. doi:10.1001/jamanetworkopen.2022.55599
Full text
Raw RK et al. (2023) Increased adverse events following third dose of BNT162b2/Pfizer vaccine in those with previous COVID-19, but not with concurrent influenza vaccine. PLOS Glob Public Health 3(2): e0001053. https://doi.org/10.1371/journal.pgph.0001053
Full text
Reis G et al. Early treatment with pegylated interferon lambda for Covid-19. NEJM. 2023 Feb 9. DOI: 10.1056/NEJMoa2209760.
Full text
Sanderson T et al. Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases. medRxiv 2023.01.26.23284998; doi: https://doi.org/10.1101/2023.01.26.23284998
Full text
Sicouri G et al. Mental health symptoms in children and adolescents during COVID-19 in Australia. Australian & New Zealand Journal of Psychiatry. 2023;57(2):213-229. doi:10.1177/00048674221090174
Full text
Tesch F et al. Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study. medRxiv 2023.01.25.23285014; doi: https://doi.org/10.1101/2023.01.25.23285014
Full text
Wahlgren C et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. The Lancet. 2023 Feb 23. DOI:https://doi.org/10.1016/j.lanepe.2023.100595
Full text
Wang S et al. Adherence to healthy lifestyle prior to infection and risk of post–COVID-19 condition. JAMA Intern Med. Published online February 06, 2023. doi:10.1001/jamainternmed.2022.6555
Full text
Wang Z et al. The emerging antimicrobial resistance crisis during the COVID-19 surge in China. The Lancet. 2023 Feb 10. DOI:https://doi.org/10.1016/S2666-5247(23)00038-1
Full text
Wei Y et al. Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 omicron. JAMA Netw Open. 2023;6(2):e2254777. doi:10.1001/jamanetworkopen.2022.54777
Full text
White BM et al. Exploring celebrity influence on public attitude towards the COVID-19 pandemic: social media shared sentiment analysis. BMJ Health & Care Informatics 2023;30:e100665. doi: 10.1136/bmjhci-2022-100665
Full text
Wong C et al. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. The Lancet. 2023 Feb 13. DOI:https://doi.org/10.1016/S1473-3099(22)00873-8
Full text
Wu N et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. The Lancet. 2023 Feb 10. DOI:https://doi.org/10.1016/S2213-2600(23)00015-2
Full text
Yip T et al. Impact of the use of oral antiviral agents on the risk of hospitalization in community coronavirus disease 2019 patients (COVID-19), Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e26–e33, https://doi.org/10.1093/cid/ciac687
Full text
Yue C et al. ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. The Lancet. 2023 Feb 03. DOI:https://doi.org/10.1016/S1473-3099(23)00010-5
Full text
January 2023
Afroze F et al. Features and risk factors of post-COVID-19 syndrome: Findings from a longitudinal study in Bangladesh. The Lancet 2023 Jan 02. doi:https://doi.org/10.1016/j.lansea.2022.100134
Full text
Andersson N W et al. Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries. medRxiv 2023.01.19.23284764; doi: https://doi.org/10.1101/2023.01.19.23284764
Full text
Bobrovitz M et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.Lancet Infec Dis. 2023 Jan 18. doi:https://doi.org/10.1016/S1473-3099(22)00801-5
Full text
Cao Z et al. VV116 versus nirmatrelvir–ritonavir for oral treatment of Covid-19. NEJM. 2022 Dec 28. doi: 10.1056/NEJMoa2208822
Full text
Davis, H.E et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023). https://doi.org/10.1038/s41579-022-00846-2
Full text
Ellis R J et al. Factors associated with hospitalisations and deaths of residential aged care residents with COVID‐19 during the Omicron (BA.1) wave in Queensland. MJA. 2023 Jan 23. doi: 10.5694/mja2.51813
Full text
Encinosa W et al. Complications, adverse drug events, high costs, and disparities in multisystem inflammatory syndrome in children vs COVID-19. JAMA Netw Open. 2023;6(1):e2244975. doi:10.1001/jamanetworkopen.2022.44975
Full text
Gottlieb M et al. Severe fatigue and persistent symptoms at three months following SARS-CoV-2 infections during the pre-delta, delta, and omicron time periods: A multicenter prospective cohort study, Clinical Infectious Diseases, 2023;, ciad045, https://doi.org/10.1093/cid/ciad045
Full text
Herman B et al. (2022) Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients. PLoS ONE 17(12): e0279184. https://doi.org/10.1371/journal.pone.0279184
Full text
Hu S et al. Multidrug-resistant infection in COVID-19 patients: A meta-analysis. J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.10.043. Epub 2022 Nov 5. PMID: 36347426; PMCID: PMC9637013.
Full text
Huang NX et al. (2023) Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19. PLoS ONE 18(1): e0280280. https://doi.org/10.1371/journal.pone.0280280
Full text
Jang EJ et al. BNT162b2 vaccine effectiveness against the SARS-CoV-2 omicron variant in children aged 5 to 11 Years. JAMA Pediatr. Published online January 09, 2023. doi:10.1001/jamapediatrics.2022.5221
Abstract
Kamal A et al. Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial. BMC Infect Dis 23, 36 (2023). https://doi.org/10.1186/s12879-023-07993-8
Full text
Khoo W H et al Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19. Clinical Immunology. Vol 246, 2023 Jan. doi: https://doi.org/10.1016/j.clim.2022.109209.
Full text
Lee D et al. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children. Science. 2022 Dec 20. doi/10.1126/science.abo3627
Full text
Malato J et al. Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months. The Lancet Infec Diseases. 2023 Jan 05. DOI:https://doi.org/10.1016/S1473-3099(22)00833-7
Full text
Massimo M et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection, Brain, 2023;, awac372, https://doi.org/10.1093/brain/awac372
Full text
McCarthy MW et al. Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: A randomized clinical trial. JAMA. 2023;329(4):296–305. doi:10.1001/jama.2022.24100
Full text
Mizrahi B et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 2023;380:e072529. doi: https://doi.org/10.1136/bmj-2022-072529
Full text
Nguyen TN et al. Global impact of the COVID-19 pandemic on stroke volumes and cerebrovascular events: A 1-year follow-up. Neurology. 2023 Jan 24;100(4):e408-e421. doi: 10.1212/WNL.0000000000201426. Epub 2022 Oct 18. PMID: 36257718.
Full text
Richard SA et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6(1):e2251360. doi:10.1001/jamanetworkopen.2022.51360
Full text
Ronen A et al. Effectiveness of the bivalent mRNA vaccine in preventing severe COVID-19 outcomes: An observational cohort study. Available at SSRN: https://ssrn.com/abstract=4314067 or http://dx.doi.org/10.2139/ssrn.4314067
Full text
Schneider FH et al. Financial incentives for vaccination do not have negative unintended consequences. Nature 613, 526–533 (2023). https://doi.org/10.1038/s41586-022-05512-4
Full text
Senefeld JW et al. COVID-19 convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. JAMA Netw Open. 2023;6(1):e2250647. doi:10.1001/jamanetworkopen.2022.50647
Full text
Shi T et al. Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China. Journal of Infection. 2023 Jan. doi:https://doi.org/10.1016/j.jinf.2022.08.041
Full text
Tang S et al. Education level modifies parental hesitancy about COVID-19 vaccinations for their children. Vaccine. 2023 Jan 9;41(2):496-503. doi: 10.1016/j.vaccine.2022.11.060. Epub 2022 Nov 29. PMID: 36494253; PMCID: PMC9705202.
Full text
Tao Ya-Chao et al. Mesenchymal stem cells therapy for COVID-19: from basic research to clinical trial, Current Stem Cell Research & Therapy 2023; 18() . https://dx.doi.org/10.2174/1574888X18666230118122256
Abstract
Tartof SY et al. Analysis of mRNA COVID-19 vaccine uptake among immunocompromised individuals in a large US health system. JAMA Netw Open. 2023;6(1):e2251833. doi:10.1001/jamanetworkopen.2022.51833
Full text
Tu WJ et al. Impact of the COVID-19 pandemic lockdown on hospitalizations for cerebrovascular disease and related in-hospital mortality in China: A nationwide observational study. Arch Gerontol Geriatr. 2023 Jan;104:104832. doi: 10.1016/j.archger.2022.104832. Epub 2022 Oct 4. PMID: 36219895; PMCID: PMC9531358.
Full text
Villar J et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. The Lancet. 2023 Jan 13. doi:https://doi.org/10.1016/S0140-6736(22)02467-9
Full text
Wan E W F et al. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank, Cardiovascular Research, 2023;, cvac195, https://doi.org/10.1093/cvr/cvac195
Full text
Wang Y et al. The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination. J Infect Public Health. 2023 Jan;16(1):125-132. doi: 10.1016/j.jiph.2022.12.004. Epub 2022 Dec 6. PMID: 36516647; PMCID: PMC9724502.
Full text
Xiao H et al. Sex, racial, and ethnic representation in COVID-19 clinical trials: A systematic review and meta-analysis. JAMA Intern Med. 2023;183(1):50–60. doi:10.1001/jamainternmed.2022.5600
Full text
December 2022
Baseler HA et al. The negative impact of COVID-19 on working memory revealed using a rapid online quiz. PLoS ONE 17(11): e0269353. https://doi.org/10.1371/journal.pone.0269353
Full text
Baskett W et al. COVID-specific long-term sequelae in comparison to common viral respiratory infections: An analysis of 17,487 infected adult patients. Open Forum Infectious Diseases, 2022;, ofac683, https://doi.org/10.1093/ofid/ofac683
Abstract
Bastain TM et al. COVID-19 pandemic experiences and symptoms of pandemic-associated traumatic stress among mothers in the US. JAMA Netw Open. 2022;5(12):e2247330. doi:10.1001/jamanetworkopen.2022.47330
Full text
Bryant JM et al. Association of time to surgery after COVID-19 infection with risk of postoperative cardiovascular morbidity. JAMA Netw Open. 2022;5(12):e2246922. doi:10.1001/jamanetworkopen.2022.46922
Full text
Brevini T et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature (2022). https://doi.org/10.1038/s41586-022-05594-0
Abstract
Bor A.et al. Discriminatory attitudes against the unvaccinated during a global pandemic. Nature (2022). https://doi.org/10.1038/s41586-022-05607-y
Full text
Burn, E.et al. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nat Commun 13, 7167 (2022). https://doi.org/10.1038/s41467-022-34668-w
Full text
Butler C et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. The Lancet. 2022 Dec 22. doi:https://doi.org/10.1016/S0140-6736(22)02597-1
Full text
Castelli J et al. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study. BMJ. 2022 Nov 30. doi: https://doi.org/10.1136/bmj-2022-073070
Full text
Chen Y et al. (2022) The third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants, Emerging Microbes & Infections, 11:1, 1524-1536, DOI: 10.1080/22221751.2022.2081614
Full text
Debski M et al. (2022) Post-COVID-19 syndrome risk factors and further use of health services in East England. PLOS Glob Public Health 2(11): e0001188. https://doi.org/10.1371/journal.pgph.0001188
Full text
Dryden-Petersen S et al. Nirmatrelvir plus ritonavir for early COVID-19 in a large U.S. health system. Annals of internal Medicine. 2022 Dec 13. doi: https://doi.org/10.7326/M22-2141
Full text
Garneau WM et al. Analysis of clinical outcomes of pregnant patients treated with Nirmatrelvir and Ritonavir for acute SARS-CoV-2 infection. JAMA Netw Open. 2022;5(11):e2244141. doi:10.1001/jamanetworkopen.2022.44141
Full text
Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604–1615. doi:10.1001/jama.2022.18931
Full text
Grasselli G et al. Association of COVID-19 vaccinations with Intensive Care Unit admissions and outcome of critically ill patients with COVID-19 pneumonia in Lombardy, Italy. JAMA Netw Open. 2022;5(10):e2238871. doi:10.1001/jamanetworkopen.2022.38871
Full text
Hedberg P et al. Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. Journal of Internal Medicine. 2022 Dec 07. Doi: https://doi.org/10.1111/joim.13584
Full text
Hoffmann A et al. Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralization. The Lancet. 2022 Dec 05. DOI:https://doi.org/10.1016/S1473-3099(22)00792-7
Full text
Huang L.et al. Comparing hybrid and regular COVID-19 vaccine-induced immunity against the Omicron epidemic. npj Vaccines 7, 162 (2022). https://doi.org/10.1038/s41541-022-00594-7
Full text
Imai M et al. Efficacy of antiviral agents against Omicron subvariants BQ.1.1 and XBB. NEJM. 2022 Dec 7. DOI: 10.1056/NEJMc2214302
Full text
Keppler-Hafkemeyer, A et al. Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma. Nat Cancer (2022). https://doi.org/10.1038/s43018-022-00502-x
Full text
Kurhade, C et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by parental mRNA vaccine or a BA.5-bivalent booster. Nat Med (2022). https://doi.org/10.1038/s41591-022-02162-x
Abstract
Lai F et al. Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis, Journal of the American College of Cardiology. 2022. Doi: https://doi.org/10.1016/j.jacc.2022.09.049
Full text
Lam J et al. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants. Emerging Microbes & Infections, 11:1, 964-967, DOI: 10.1080/22221751.2022.2053365
Full text
Lee LYW et al. Association of SARS-CoV-2 spike protein antibody vaccine response with infection severity in patients with cancer: A national COVID cancer cross-sectional evaluation. JAMA Oncol. Published online December 22, 2022. doi:10.1001/jamaoncol.2022.5974
Full text
Lee M et al. Parental acceptance of COVID-19 vaccination for children and Its association with information sufficiency and credibility in South Korea. JAMA Netw Open. 2022;5(12):e2246624. doi:10.1001/jamanetworkopen.2022.46624
Full text
Liew F et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. The Lancet. 2022 Dec 19. DOI:https://doi.org/10.1016/j.ebiom.2022.104402
Full text
Llor C et al. Evaluation of publication of COVID-19–related articles initially presented as preprints. JAMA Netw Open. 2022;5(12):e2245745. doi:10.1001/jamanetworkopen.2022.45745
Full text
Magnusson, K et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun 13, 7363 (2022). https://doi.org/10.1038/s41467-022-35240-2
Full text
McQuilten Z et al. Anticoagulation strategies in non–critically ill patients with Covid-19. NEJM. 2022 Dec 10. DOI:https://doi.org/10.1056/EVIDoa2200293
Full text
Mueller, J et al. (2022). Two masks can be worse than one: N95 respirator failure caused by an overlying face mask. Infection Control & Hospital Epidemiology, 1-3. doi:10.1017/ice.2022.277
Full text
Naggie S et al. Effect of Ivermectin 600 μg/kg for 6 days vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: A randomized clinical trial. 2022 Dec 15. doi: https://doi.org/10.1101/2022.12.15.22283488
Full text
Nielsen KF et al. (2022) Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study. PLoS Med 19(11): e1004037. https://doi.org/10.1371/journal.pmed.1004037
Full text
O’Mahoney L et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. The Lancet. 2022 Dec 01. DOI:https://doi.org/10.1016/j.eclinm.2022.101762
Full text
Pinto Pereira S et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: A prospective follow-up study over 12 months. The Lancet. 2022 Dec 04. DOI:https://doi.org/10.1016/j.lanepe.2022.100554
Full text
Robinson M et al. Impact of SARS-CoV-2 variants on inpatient clinical outcome, Clinical Infectious Diseases, 2022;, ciac957, https://doi.org/10.1093/cid/ciac957
Full text
Smith DM et al. Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19. JAMA Netw Open. 2022;5(10):e2238867. doi:10.1001/jamanetworkopen.2022.38867
Full text
Stein S.R et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758–763 (2022). https://doi.org/10.1038/s41586-022-05542-y
Full text
Tsang N et al. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. The Lancet. 2022 Dec 12. DOI:https://doi.org/10.1016/S1473-3099(22)00732-0
Full text
Wang C et al. Association between COVID-19 vaccination and artificial insemination outcomes for couples experiencing infertility. JAMA Netw Open. 2022;5(12):e2247216. doi:10.1001/jamanetworkopen.2022.47216
Full text
Wang Q et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2022 Dec 13. DOI:https://doi.org/10.1016/j.cell.2022.12.018
Full text
Tu W et al. 2023: SARS-CoV-2 infection, hospitalization, and death in vaccinated and infected Individuals by age groups in Indiana, 2021‒2022 American Journal of Public Health 113, 96_104, https://doi.org/10.2105/AJPH.2022.307112
Full text
Weatherald J et al. Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials BMJ 2022; 379 :e071966 doi:10.1136/bmj-2022-07196
Full text
Wong CKH et al. Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study. Lancet Infect Dis. 2022 Dec;22(12):1681-1693. doi: 10.1016/S1473-3099(22)00507-2. Epub 2022 Aug 24. PMID: 36029795; PMCID: PMC9401976.
Full text
Wong GL et al. Incidence of viral rebound after treatment with Nirmatrelvir-Ritonavir and Molnupiravir. JAMA Netw Open. 2022;5(12):e2245086. doi:10.1001/jamanetworkopen.2022.45086
Full text
Writing Committee for the REMAP-CAP Investigators. Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP Randomized Clinical Trial. JAMA. Published online December 16, 2022. doi:10.1001/jama.2022.23257
Full text
Xiao H et al. Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis. JAMA Intern Med. Published online December 05, 2022. doi:10.1001/jamainternmed.2022.5600
Full text
Xie Z et al. Concerns about and stimuli of COVID-19 vaccination hesitancy among diverse occupational groups in metropolitan areas of China: a cross-sectional study. BMJ Open 2022;12:e062032. doi: 10.1136/bmjopen-2022-062032
Full text
Yan E et al. Physical, psychological and pandemic fatigue in the fourth wave of COVID-19 outbreak in Hong Kong: population-based, cross-sectional study. BMJ Open 2022;12:e062609. doi: 10.1136/bmjopen-2022-062609
Full text
Young D et al. Associations of physical inactivity and COVID-19 outcomes among subgroups. American Journal of Preventive Medicine. 2022 Dec 14. doi:https://doi.org/10.1016/j.amepre.2022.10.007
Full text
Zhang X et al. Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines. The Lancet. 2022 Dec 06. DOI:https://doi.org/10.1016/S2666-5247(22)00335-4
Full text
Zhou R et al. Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: A population-based study in Hong Kong. The Lancet. 2022 Dec 23. DOI:https://doi.org/10.1016/j.lanwpc.2022.100660
Full text
Zhu Z et al. Association of glucose-lowering drugs with outcomes in patients with diabetes before hospitalization for COVID-19: A systematic review and network meta-analysis. JAMA Netw Open. 2022;5(12):e2244652. doi:10.1001/jamanetworkopen.2022.44652
Full text
November 2022
Arora P et al. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. The Lancet Infectious Disease. 2022 Nov 18. doi:https://doi.org/10.1016/S1473-3099(22)00733-2
Full text
Bertran M et al. (2022) COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study. PLoS Med 19(11): e1004118. https://doi.org/10.1371/journal.pmed.1004118
Full text
Bettinger JA et al, Adverse events following immunization with mRNA and viral vector vaccines in individuals with previous Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection from the Canadian National Vaccine Safety Network, Clinical Infectious Diseases, 2022;, ciac852, https://doi.org/10.1093/cid/ciac852
Full text
Bowe, B et al. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398–2405 (2022). https://doi.org/10.1038/s41591-022-02051-3
Full text
Chemaitelly H et al. Covid-19 vaccine protection among children and adolescents in Qatar. NEJM N Engl J Med 2022 Nov 17; 387:1865-1876 DOI: 10.1056/NEJMoa2210058
Full text
Collie S et al. Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case–control study. British Journal of Sports Medicine Published Online First: 24 October 2022. doi: 10.1136/bjsports-2022-105734
Full text
Cowger T et al. Lifting Universal Masking in Schools — Covid-19 Incidence among Students and Staff NEJM 2022 Nov 8 doi: 10.1056/NEJMoa2211029
Full text
Dai Z et al. (2022) Influencing factors of anxiety and depression of discharged COVID-19 patients in Wuhan, China. PLoS ONE 17(11): e0276608. https://doi.org/10.1371/journal.pone.0276608
Full text
Ebinger J et al. Hypertension and excess risk for severe COVID-19 illness despite booster vaccination. Hypertension. 2022;79:e132–e134. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.122.19694
Full text
Fabiani M et al. Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study. Vaccine. 2022 Nov 14. https://doi.org/10.1016/j.vaccine.2022.11.013.
Full text
Fernández-de-las-Peñas C et al. Post–COVID-19 symptoms 2 Years After SARS-CoV-2 infection among hospitalized vs nonhospitalized patients. JAMA Netw Open. 2022;5(11):e2242106. doi:10.1001/jamanetworkopen.2022.42106
Full text
Flannery DD et al. Comparison of maternal and neonatal antibody levels after COVID-19 vaccination vs SARS-CoV-2 infection. JAMA Netw Open. 2022;5(11):e2240993. doi:10.1001/jamanetworkopen.2022.40993
Full text
Focosi D et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5. Erratum in: Lancet Infect Dis. 2022 Sep;22(9):e239. PMID: 35803289; PMCID: PMC9255948.
Full text
Gosdin L et al. Six-month outcomes of infants born to people with SARS-CoV-2 in pregnancy. Paediatrics. 2022 Nov 1. https://doi.org/10.1542/peds.2022-059009
Full text
Granados Samayoa JA et al. (2022) A gateway conspiracy? Belief in COVID-19 conspiracy theories prospectively predicts greater conspiracist ideation. PLoS ONE 17(10): e0275502. https://doi.org/10.1371/journal.pone.0275502
Full text
Hui L et al. Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: a multi-center cohort study of vaccination uptake and perinatal outcomes. AJOG. 2022 Nov 3. doi:https://doi.org/10.1016/j.ajog.2022.10.040
Full text
Li X et al. Efficacy and safety of COVID-19 inactivated vaccine: A meta-analysis. Front Med (Lausanne). 2022 Nov 7;9:1015184. doi: 10.3389/fmed.2022.1015184. PMID: 36419789; PMCID: PMC9676443.
Full text
Looi M et al. Has covid-19 become milder? BMJ 2022 Oct 27; 379 doi: https://doi.org/10.1136/bmj.o2516
Full text
Meisner J et al. Household transmission of SARS-CoV-2 from humans to pets, Washington and Idaho, USA. Emerg Infect Dis. 2022;28(12):2425-2434. https://doi.org/10.3201/eid2812.220215
Full text
McQuaid C.F. et al. Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries. BMC Med 20, 432 (2022). https://doi.org/10.1186/s12916-022-02624-6
Full text
Miller J et al. Substantial neutralization escape by the SARS-CoV-2 Omicron variant BQ.1.1. bioRxiv 2022.11.01.514722; doi: https://doi.org/10.1101/2022.11.01.514722
Full text
O’Hare AM et al. Complexity and challenges of the clinical diagnosis and management of long COVID. JAMA Netw Open. 2022;5(11):e2240332. doi:10.1001/jamanetworkopen.2022.40332
Full text
Pavey H et al. (2022) Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank. PLoS ONE 17(11): e0276781. https://doi.org/10.1371/journal.pone.0276781
Full text
Qu, Y. et al. A novel method to monitor COVID-19 fatality rate in real-time, a key metric to guide public health policy. Sci Rep 12, 18277 (2022). https://doi.org/10.1038/s41598-022-23138-4
Full text
Qu M et al. Symptoms of anxiety and depression among adolescents before vs during COVID-19–related school closures in China. JAMA Netw Open. 2022;5(11):e2241752. doi:10.1001/jamanetworkopen.2022.41752
Full text
Summan A et al. The effect of the COVID-19 pandemic on routine childhood immunization coverage and timeliness in India: Retrospective analysis of the National Family Health Survey of 2019–2021 data. The Lancet Regional Health South East Asia. 2022 Nov 6. doi:https://doi.org/10.1016/j.lansea.2022.100099
Full text
Schwartz K et al. Real-world effectiveness of nirmatrelvir/ritonavir use for COVID-19: A population-based cohort study in Ontario, Canada. medRxiv 2022.11.03.22281881; doi: https://doi.org/10.1101/2022.11.03.22281881
Full text
Su X et al. COVID-19 vaccine hesitancy in periconceptional and lactating women: a systematic review and meta-analysis protocol. BMJ Open 2022;12:e059514. doi: 10.1136/bmjopen-2021-059514
Full text
Tan B et al. Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study. eClinicalMedicine. 2022 Nov 7. doi:https://doi.org/10.1016/j.eclinm.2022.101724
Full text
Tang L et al. Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study. BMJ Open 2022;12:e063919. doi: 10.1136/bmjopen-2022-063919
Full text
Taquet T et al. Incidence of epilepsy and seizures over the first 6 months after a COVID-19 diagnosis: A retrospective cohort study. Neurology Nov 2022, 10.1212/WNL.0000000000201595; doi: 10.1212/WNL.0000000000201595
Full text
Tartof S et al. BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5. The Lancet Infectious Diseases. 2022 Oct 25. doi:https://doi.org/10.1016/S1473-3099(22)00692-2
Full text
Tompkins L K et al. Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults. Vaccine. 2022 Nov 1. https://doi.org/10.1016/j.vaccine.2022.10.073.
Wei H-Y et al. Probable aerosol transmission of SARS-CoV-2 through floors and walls of quarantine hotel, Taiwan, 2021. Emerg Infect Dis. 2022 Dec https://doi.org/10.3201/eid2812.220666
Full text
Wu, PC et al. New onset and exacerbations of psoriasis following COVID-19 vaccines: A systematic review. Am J Clin Dermatol 23, 775–799 (2022). https://doi.org/10.1007/s40257-022-00721-z
Full text
Xie Y et al. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. medRxiv 2022.11.03.22281783; doi: https://doi.org/10.1101/2022.11.03.22281783
Full text
Xu H et al. (2022) Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: Real-world study in Jilin Province, China, Emerging Microbes & Infections, doi: 10.1080/22221751.2022.2149935
Full text
Xu S et al. Covid-19 vaccine effectiveness during Omicron BA.2 pandemic in Shanghai: A cross-sectional study based on EMR. Medicine (Baltimore). 2022 Nov 11;101(45):e31763. doi: 10.1097/MD.0000000000031763. PMID: 36397325; PMCID: PMC9665889.
Full text
Yechezkel M et al. Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study. The Lancet Respiratory Medicine. 2022 Nov 18. doi:https://doi.org/10.1016/S2213-2600(22)00407-6
Full text
Zhang, T et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med 20, 444 (2022). https://doi.org/10.1186/s12916-022-02656-y
Full text
Zhang, X et al. COVID-19 Breakthrough infections in vaccinated kidney transplant recipients. Vaccines 2022, 10, 1911. https://doi.org/10.3390/vaccines10111911
Full text
October 2022
Agrawal U et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022 Oct 15. doi:https://doi.org/10.1016/S0140-6736(22)01656-7
Full text
Anderson E J et al. Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age. NEJM. 2022 Oct 19. doi: 10.1056/NEJMoa2209367
Full text
Antoon J et al. COVID-19 and acute neurologic complications in children. Paediatrics e2022058167. 2022 Oct 20; doi: https://doi.org/10.1542/peds.2022-058167
Full text
Carazo S et al. Estimated protection of prior SARS-CoV-2 infection against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and nonvaccinated individuals in Quebec, Canada. JAMA Netw Open. 2022;5(10):e2236670. doi:10.1001/jamanetworkopen.2022.36670
Full text
Daitch V et al. Characteristics of long COVID among older adults: a cross-sectional study. International Journal of Infectious Diseases. 2022 Sep 30. doi:https://doi.org/10.1016/j.ijid.2022.09.035
Full text
Edelman A et al. Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data. BMJ. 2022 Aug 8. doi: http://dx.doi.org/10.1136/bmjmed-2022-000297
Full text
Ferdinands J M et al. Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study BMJ 2022; 379 :e072141 doi:10.1136/bmj-2022-072141
Full text
Hastie, C.E et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun 13, 5663 (2022). https://doi.org/10.1038/s41467-022-33415-5
Full text https://www.nature.com/articles/s41467-022-33415-5
Hermann EA et al. Association of symptoms after COVID-19 vaccination with anti–SARS-CoV-2 antibody response in the Framingham Heart Study. JAMA Netw Open. 2022;5(10):e2237908. doi:10.1001/jamanetworkopen.2022.37908
Full text
Jalali, N.et al. Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants. Nat Commun 13, 5706 (2022). https://doi.org/10.1038/s41467-022-33233-9
Full text
La Y et al. Increase of multidrug-resistant bacteria after the COVID-19 pandemic in South Korea: Time-series analyses of a long-term multicenter cohort. Journal of Infection. 2022 Sep 29. doi:https://doi.org/10.1016/j.jinf.2022.09.026
Full text
Mimura W et al. Effectiveness of mRNA vaccines against SARS-CoV-2 infections during the periods of Delta and Omicron variant predominance in Japan: The VENUS Study. International Journal of Infectious Diseases. 2022 Oct 08. doi:https://doi.org/10.1016/j.ijid.2022.10.001
Full text
Naggie S et al. Effect of Ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: A randomized clinical trial. JAMA. 2022;328(16):1595–1603. doi:10.1001/jama.2022.18590
Full text
Nelson L et al. Robustness of evidence reported in preprints during peer review. Lancet. 2022, Nov 01. doi:https://doi.org/10.1016/S2214-109X(22)00368-0
Full text
Poon, YS.R. et al. A global overview of healthcare workers’ turnover intention amid COVID-19 pandemic: a systematic review with future directions. Hum Resour Health 20, 70 (2022). https://doi.org/10.1186/s12960-022-00764-7
Full text
Raisi-Estabragh Z et al Cardiovascular disease and mortality sequelae of COVID-19 in the UK BiobankHeart Published Online First: 24 October 2022. doi: 10.1136/heartjnl-2022-321492
Full text
Stock S J et al. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet. 2022 Oct 07. doi:https://doi.org/10.1016/S2213-2600(22)00360-5
Full text
Sutin AR et al. (2022) Differential personality change earlier and later in the coronavirus pandemic in a longitudinal sample of adults in the United States. PLoS ONE 17(9): e0274542. https://doi.org/10.1371/journal.pone.0274542
Full text
The HEROES-RECOVER Network. Association of mRNA vaccination with clinical and virologic features of COVID-19 among US essential and frontline workers. JAMA. 2022;328(15):1523–1533. doi:10.1001/jama.2022.18550
Full text
Toepfner N et al. Comparative safety of the BNT162b2 messenger RNA COVID-19 vaccine vs other approved vaccines in children younger than 5 Years. JAMA Netw Open. 2022;5(10):e2237140. doi:10.1001/jamanetworkopen.2022.37140
Full text
Tsao J et al. Prevalence of positive rapid antigen tests after 7-day isolation following SARS-CoV-2 infection in college athletes during omicron variant predominance. JAMA Netw Open. 2022;5(10):e2237149. doi:10.1001/jamanetworkopen.2022.37149
Full text
Wang X et al. COVID-19 vaccination status and associated factors among lactating women during the COVID-19 outbreak: a cross-sectional study in southern China. BMJ Open 2022;12:e062447. doi: 10.1136/bmjopen-2022-062447
Full text
Woo CJ et al. Ramsay Hunt syndrome following COVID-19 vaccination. Postgraduate Medical Journal 2022;98:738-739.
Full text
Wong C et al. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet. 2022 Oct 08. doi:https://doi.org/10.1016/S0140-6736(22)01586-0.
Full text
Zhang Z et al. Thyroid function and COVID-19 Susceptibility and its severity: A two-sample Mendelian randomization study. Endocrinology. 2022 Oct 11;163(11):bqac139. doi: 10.1210/endocr/bqac139. PMID: 36048436.
Full text
Zheng Q et al. Efficacy and safety of Paxlovid for COVID-19: a meta-analysis. Journal of Infection. 2022 September 30. doi:https://doi.org/10.1016/j.jinf.2022.09.027
Full text
September 2022
Ammirati E et al. Recovery from mRNA COVID-19 vaccine-related myocarditis. Lancet. 2022 Sep 21; doi:https://doi.org/10.1016/S2352-4642(22)00272-3
Full text
Carazo S et al. Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. Lancet 2022 Sep 21; doi:https://doi.org/10.1016/S1473-3099(22)00578-3
Full text
Chalkias S et al. A Bivalent Omicron-Containing Booster Vaccine against Covid-19. 2022 Sep 16; doi: 10.1056/NEJMoa2208343
Full text
Chen F et al. The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms. Transl Neurodegener. 2022 Sep 11;11(1):40. doi: 10.1186/s40035-022-00316-y. PMID: 36089575; PMCID: PMC9464468.
Full text
Costa M L et al. COVID-19 in pregnancy: evidence from LMICs. Lancet 2022 Sep 22; doi:https://doi.org/10.1016/S2214-109X(22)00410-7
Full text
Drain PK et al. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants. JAMA Netw Open. 2022;5(8):e2228143. doi:10.1001/jamanetworkopen.2022.28143
Full text
Hartung TJ et al. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. Lancet. 2022 Sep 17; doi:https://doi.org/10.1016/j.eclinm.2022.101651
Full text
Huang L et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11. PMID: 35568052; PMCID: PMC9094732.
Full text
Kendall EK et al. Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021. JAMA Netw Open. 2022;5(9):e2233014. doi:10.1001/jamanetworkopen.2022.33014
Full text
Knight R et al. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation. 2022 Sep 20; doi: https://doi.org/10.1161/CIRCULATIONAHA.122.060785
Full text
Mendes P et al. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction. JAMA Netw Open. 2022;5(9):e2230637. doi:10.1001/jamanetworkopen.2022.30637
Full text
Puntmann, V.O.et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med (2022). doi: https://doi.org/10.1038/s41591-022-02000-0
Full text
Rubin E J et al. Audio Interview: Can Vaccines Prevent Transmission of Covid-19? N Engl J Med. 2022 Sep 22; doi: 10.1056/NEJMe2212576
Full text
Tian Y et al. Thyroid diseases are associated with coronavirus disease 2019 infection. Front Endocrinol (Lausanne). 2022 Sep 2;13:952049. doi: 10.3389/fendo.2022.952049. PMID: 36120425; PMCID: PMC9478801.
Full text
Tison G H et al. Worldwide physical activity trends since COVID-19 onset. Lancet 2022 Aug 31; 10 (10) E1381-E1382 https://doi.org/10.1016/S2214-109X(22)00361-8
Full text
Waltz E. China and India approve nasal COVID vaccines - are they a game changer? Nature. 2022 Sep;609(7927):450. doi: 10.1038/d41586-022-02851-0. PMID: 36071228.
Full text
Wang, Q et al. Mapping global acceptance and uptake of COVID-19 vaccination: A systematic review and meta-analysis. Commun Med 2, 113 (2022). https://doi.org/10.1038/s43856-022-00177-6
Full text
Yang X et al. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China. JAMA Netw Open. 2022;5(9):e2231790. doi:10.1001/jamanetworkopen.2022.31790
Full text
August 2022
Arbel R et al. Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. N Engl J Med. 2022 Aug 24 doi: 10.1056/NEJMoa2204919
Full text
Ballering AV et al. Persistence of somatic symptoms after covid-19 in the Netherlands: an observational cohort study. Lancet 2022;400:452-61 doi:https://doi.org/10.1016/S0140-6736(22)01214-4
Full text
Bramante CT et al. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med 2022 Aug 18 ;387:599-610. doi: 10.1056/NEJMoa2201662
Full text
Drain PK et al. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants. JAMA Netw Open. 2022;5(8):e2228143. doi:10.1001/jamanetworkopen.2022.28143
Full text
Faust et al. Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state. Lancet 2022 Aug 22: doi: https://doi.org/10.1016/S1473-3099(22)00547-3
Full text
Gavrilaki E et al. COVID-19 sequelae: can long-term effects be predicted? Lancet 2022 Aug 25 doi: https://doi.org/10.1016/S1473-3099(22)00529-1
Full text
Gregersen R et al. Association of COVID-19 Infection With Wearing Glasses in a High-Prevalence Area in Denmark and Sweden. JAMA Ophthalmol. Published online August 25, 2022. doi:10.1001/jamaophthalmol.2022.3234
Full text
Kim S et al, Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries. PLOS Medicine. 2022 Aug 16, https://doi.org/10.1371/journal.pmed.1004060
Full text
Ng OT et al. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore. JAMA Netw Open. 2022;5(8):e2228900. doi:10.1001/jamanetworkopen.2022.28900
Full text
Ryu S et al. Association Between the Relaxation of Public Health and Social Measures and Transmission of the SARS-CoV-2 Omicron Variant in South Korea. JAMA Netw Open. 2022;5(8):e2225665. doi:10.1001/jamanetworkopen.2022.25665
Full text
Sandarangani M et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study. Lancet. 2022 Aug 11; doi:https://doi.org/10.1016/S1473-3099(22)00426-1
Full text
Stepanova, M et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis 22, 702 (2022). https://doi.org/10.1186/s12879-022-07657-z
Full text
Shui X et al. COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis. PLoS One. 2022 Aug 12;17(8):e0273112. doi: 10.1371/journal.pone.0273112. PMID: 35960730; PMCID: PMC9374244.
Full text
Taquet M et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet. 2022 Aug 18; doi: https://doi.org/10.1016/S2215-0366(22)00260-7
Full text
July 2022
Barnette K et al, Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis, NEJM Evidence, Published July 6, 2022 DOI: https://doi.org/10.1056/EVIDoa2200145,
Full text
Choi D et al. Association of Blood Viscosity With Mortality Among Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2022 Jul, 80 (4) 316–328. DOI: https://doi.org/10.1016/j.jacc.2022.04.060
Full text
Fallach N et al, Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study. PLOS. Published: July 20, 2022. DOI: https://doi.org/10.1371/journal.pone.0270893
Full text:
Goddard K et al, Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination, Vaccine, Published July 12,2022, DOI: https://doi.org/10.1016/j.vaccine.2022.07.007
Full text
Kim Y et al, Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA. Published online July 22, 2022. doi:10.1001/jama.2022.12992
Full text
Lee K et al, Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination Science Advances, Published 15 Jul 2022 Vol 8, Issue 28 DOI: 10.1126/sciadv.abm7201
Full text
Nygaard U et al, Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5 to 11 Years, Paediatrics, Published 26 July 2022, DOI: https://doi.org/10.1542/peds.2022-057508
Full text
Piernas C et al. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. The Lancet Infectious Diseases, Published: June 30, 2022, DOI: https://doi.org/10.1016/S2213-8587(22)00158-9
Full text
Pitre T et al, Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis CMAJ July 25, 2022 194 (28) E969-E980; DOI: https://doi.org/10.1503/cmaj.220471
Full text
Schneiderman M et al, Incidence and Relative Risk of COVID-19 in Adolescents and Youth Compared With Older Adults in 19 US States, Fall 2020. JAMA Netw Open. 2022;5(7):e2222126. doi:10.1001/jamanetworkopen.2022.22126
Full text
Tan S et al, Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age. NEJM Published July 20, 2022, DOI: 10.1056/NEJMoa2203209
Full text
Zilberman-Itskovich, S et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep 12, 11252 (2022). https://doi.org/10.1038/s41598-022-15565-0
Full text
June 2022
Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med , 25 May 2022 DOI: https://doi.org/10.1038/s41591-022-01840-0
Full text
Antonelli A, et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. The Lancet, Published: June 18, 2022, DOI:https://doi.org/10.1016/S0140-6736(22)00941-2
Full text
Au WY, Cheung P P-H. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2022-069989 (Published 31 May 2022)
Full text
Brownscombe JJ. et al. COVID‐19 highlights the need for action on pulse oximeter accuracy in people with dark skin. Med J Aust 2022; 216 (10): 539-539. || doi: 10.5694/mja2.51522 , Published online: 6 June 2022.
Full text
Cao, Y., Yisimayi, A., Jian, F. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature (2022). https://doi.org/10.1038/s41586-022-04980-y
Abstract
Dickerman BA, et al. Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans. AMA Intern Med. Published online June 13, 2022. doi:10.1001/jamainternmed.2022.2109
Full text
Harper T, Attwell K. How Vaccination Rumours Spread Online: Tracing the Dissemination of Information Regarding Adverse Events of COVID-19 Vaccines. Int J Public Health, 30 May 2022 DOI: https://doi.org/10.3389/ijph.2022.1604228
Full text
Higdon M, et al. Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant. The Lancet Infectious Diseases, Published: June 22, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00409-1
Full text
Liu, X. et al. Safety and superior immunogenicity of heterologous boosting with an1
RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults. medRxiv preprint, DOI https://doi.org/10.1101/2022.05.30.22275753, May 31, 2022.
Full text
Najjar-Debbiny R. et al. Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients. Clinical Infectious Diseases, ciac443, DOI: https://doi.org/10.1093/cid/ciac443 Published: 02 June 2022.
Full text
Patel M, et al. Increasing children's global access to COVID-19 vaccines. The Lancet Volume 399, ISSUE 10342, P2171-2173, June 11, 2022. DOI: https://doi.org/10.1016/S0140-6736(22)00884-4
Full text
Reynolds CJ, et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science, 14 Jun 2022, DOI: 10.1126/science.abq1841
Full text
Rowntree LC, et al. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection. Immunity, 2022; DOI: 10.1016/j.immuni.2022.06.003
Full text
Straus W, et al. Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide. Clinical Infectious Diseases, ciac446, https://doi.org/10.1093/cid/ciac446
Published: 06 June 2022.
Full text
Sylvester SV, et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. CMR, Published online: 20 Jun 2022. DOI: https://doi.org/10.1080/03007995.2022.2081454.
Full text
Vadrevu KM, et al. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. The Lancet Infectious Diseases, PublishedJune 16, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00307-3.
Full text
Watson, OJ. et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.The Lancet: Infectious Diseases, Published:June 23, 2022 DOI:https://doi.org/10.1016/S1473-3099(22)00320-6
Full text
Wu M, et al. Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees. Science Advances 3 Jun 2022, Vol 8, Issue 22, DOI: 10.1126/sciadv.abn6064
Full text
Yang H. et al. The effect of strict lockdown on Omicron SARS-CoV-2 variant transmission in Shanghai. medRxiv Posted June 07, 2022. doi: https://doi.org/10.1101/2022.05.22.22275423
Full text
Yao, L et al. Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection. The Lancet Infectious Diseases, Published: June 20, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00410-8
Full text
Ye X, et al. Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease, Cardiovascular Research, 22 June 2022, cvac068, https://doi.org/10.1093/cvr/cvac068
Full text
May 2022
Arbel, R., Sergienko, R., Friger, M. et al. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nat Med (2022). https://doi.org/10.1038/s41591-022-01832-0
Full text
Ayoubkhani, D. et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-069676 (Published 18 May 2022)
Full text
Cai, J., Deng, X., Yang, J. et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med (2022). https://doi.org/10.1038/s41591-022-01855-7
Full text
Callaway, E. Flu vaccine could cut COVID risk. Nature 605, 602 (2022), 16 May 2022,
doi: https://doi.org/10.1038/d41586-022-01315-9
Full text
Cameron A. Smith, Christian A. Yates, Ben Ashby. Critical weaknesses in shielding strategies for COVID-19. PLOS Global Public Health, 2022; 2 (4): e0000298 DOI: 10.1371/journal.pgph.0000298
Full text
Chen, F et al. The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, Published:May 10, 2022
DOI:https://doi.org/10.1016/j.ijid.2022.05.016
Full text
Cheng, SMS. et al. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022. Eurosurveillance , Volume 27, Issue 18, 05/May/2022
Full text
Fisman, DN. et al. Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission. CMAJ April 25, 2022 194 (16) E573-E580; DOI: https://doi.org/10.1503/cmaj.212105
Full text
Gazit, S. et al. Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2022-071113 (Published 24 May 2022)
Full text
Hampshire, A . et al. Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. eClinical Medicine Published:April 28, 2022DOI:https://doi.org/10.1016/j.eclinm.2022.101417
Full text
Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respiratory Medicine, Published: May 11, 2022DOI:https://doi.org/10.1016/S2213-2600(22)00126-6
Full text
Jung J, Kim JY, Park H, et al. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals. JAMA Netw Open. 2022;5(5):e2213606. doi:10.1001/jamanetworkopen.2022.13606
Full text
Li, J et al. Recent SARS‐CoV‐2 infection: too early to vaccinate? Med J Aust 2022; 216 (9): 449-451. || doi: 10.5694/mja2.51499, Published online: 25 April 2022.
Full text
McCafferty, C., Cai, T., Borgel, D. et al. Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C. Nat Commun 13, 2391 (2022). https://doi.org/10.1038/s41467-022-29951-9
Full text
Nam SY, Jeon SW, Lee HS, Lim HJ, Lee DW, Yoo SS. Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses. JAMA Netw Open. 2022;5(5):e2212996. doi:10.1001/jamanetworkopen.2022.12996
Full text
Qiao, W., Lau, H.E., Xie, H. et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun 13, 2539 (2022). https://doi.org/10.1038/s41467-022-30195-w
Full text
Seo, S., Han, JO., Shin, S. et al. Development of a social distancing monitoring system in Republic of Korea: results of a modified Delphi process. BMC Public Health 22, 860 (2022). https://doi.org/10.1186/s12889-022-13277-8
Full text
Sharma, A. et al. Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant, Clinical Infectious Diseases, 2022;, ciac325, https://doi.org/10.1093/cid/ciac325
Full text
Tong, L et al. A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nature Metabolism, Published: 09 May 2022
Full text
Xue L, Jing S, Zhang K, Milne R, Wang H. Infectivity versus fatality of SARS-CoV-2 mutations and influenza [published online ahead of print, 2022 May 15]. Int J Infect Dis. 2022;S1201-9712(22)00295-8. doi:10.1016/j.ijid.2022.05.031
Full text
Yamasoba, D. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell May 01, 2022DOI:https://doi.org/10.1016/j.cell.2022.04.035
Full text
Young R. Jang, et al. Clinical Features and Duration of Viral Shedding Individuals with SARS-CoV-2 Omicron Variant Infection, Open Forum Infectious Diseases, 2022;, ofac237, https://doi.org/10.1093/ofid/ofac237
Full text
April 2022
Aknin, LB et al. Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries. The Lancet Public Health, April 21, 2022, DOI:https://doi.org/10.1016/S2468-2667(22)00060-3
Full text
Bar-On YM. et al. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. NEJM April 5, 2022, DOI: 10.1056/NEJMoa2201570
Full text
Block, JP et al. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination. MMWR Morb Mortal Wkly Rep 2022;71:517-523. DOI: http://dx.doi.org/10.15585/mmwr.mm7114e1
Full text
Chen C et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. The Journal of Infectious Diseases, 16 April 2022 DOI: https://doi.org/10.1093/infdis/jiac136
Full text
Chen G-L. et al. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Microbe
. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9
Full text
Chen, Z. et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing, Nature Genetics (2022). DOI: 10.1038/s41588-022-01033-y
Full text
Cui, D, et al. Rheumatic symptoms following COVID-19: a chronic post COVID-19 condition. Open Forum Infectious Diseases, 04 April 2022, DOI: https://doi.org/10.1093/ofid/ofac170
Abstract
Han, JH et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza and Other Respiratory Viruses, 28 March 2022, DOI https://doi.org/10.1111/irv.12980
Full text
Katsoularis, I et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-069590 (Published 06 April 2022)
Full text
Ledford, H. Can drugs reduce the risk of long COVID? What scientists know so far. Nature, 25 March 2022, DOI d41586-022-00823-y
Full text
Ling RR et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. The Lancet Respiratory Medicine, April 11, 2022, DOI:https://doi.org/10.1016/S2213-2600(22)00059-5
Full text
Menni, C et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet, April 07, 2022, DOI:https://doi.org/10.1016/S0140-6736(22)00327-0
Full text
Moffitt, TE et al, Deep-seated psychological histories of COVID-19 vaccine hesitance and resistance, PNAS Nexus (2022). DOI: 10.1093/pnasnexus/pgac034
Full text
Morens DM et al. The Concept of Classical Herd Immunity May Not Apply to COVID-19. Journal of Infectious Diseases, 31 March 2022, DOI https://doi.org/10.1093/infdis/jiac109
Full text
Price, AM et al. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. NEJM March 30, 2022, DOI: 10.1056/NEJMoa2202826
Full text
Ridgway, JP et al. Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19. JAMA Netw Open. 2022;5(4):e227650. doi:10.1001/jamanetworkopen.2022.7650
Full text
Smith, DJ et al. COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022. MMWR Morb Mortal Wkly Rep 2022;71:545-548. DOI: http://dx.doi.org/10.15585/mmwr.mm7115e1external icon.
Full text
Wan, KH et al. Ocular surface disturbance in patients after acute COVID-19. Clin Exper Ophthalmology. 23 Feb 2022, DOI https://doi.org/10.1111/ceo.14066
Full text
Watson, C. Diabetes risk rises after COVID, massive study finds. Nature, 31 March 2022, DOI d41586-022-00912-y
Full text
Zachreson C et al. COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2. Science Advances, 8 Apr 2022 • Vol 8, Issue 14 • DOI: 10.1126/sciadv.abm3624
Full text
Influenza and COVID-19
Swets, MC. et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. The Lancet, 2022; DOI: 10.1016/S0140-6736(22)00383-X
Full text
March 2022
Alboksmaty, A et al. Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19: a systematic review. The Lancet: Digital Health Volume 4, ISSUE 4, e279-e289, April 01, 2022. DOI: 10.1016/S2589-7500(21)00276-4
Full text
Allotey, J et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ 2022; 376 doi: 10.1136/bmj-2021-067696 (Published 16 March 2022)
Full text
Arsenault, C., Gage, A., Kim, M.K. et al. COVID-19 and resilience of healthcare systems in ten countries. Nat Med (2022). DOI: 10.1038/s41591-022-01750-1
Full text
Arunachalam, PS et al. Durable protection against SARS-CoV-2 Omicron iBionduced by an adjuvanted subunit vaccine. BioRxiv 20 March 2022 DOI: 10.1101/2022.03.18.484950
Full text
Douaud, G et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. Published online March 7, 2022. doi:10.1038/s41586-022-04569-5.
Full text
Gandhi, S., Klein, J., Robertson, A.J. et al. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nat Commun 13, 1547, 17 March 2022. DOI: 10.1038/s41467-022-29104-y
Full text
Luo, B et al. Acidity of expiratory aerosols controls the infectivity of airborne influenza virus and SARS-CoV-2. medRxiv, 14 March 2022. DOI: 10.1101/2022.03.14.22272134
Full text
Messiah, SA et al. Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents. Pediatrics,18 March (2022), DOI: 10.1542/peds.2021-055505
Full text
Rathmann, W et al. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia, 16 March 2022, DOI: 10.1007/s00125-022-05670-0
Full text
Regev-Yochay, G et al. 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC. medRxiv , 15 February 2022, doi: 10.1101/2022.02.15.22270948
Full text
Takahash K et al. Duration of infectious virus shedding by SARS-CoV-2 Omicron variant–infected vaccinees. Emerg Infect Dis. 2022 May. Original Publication Date: March 15, 2022, DOI: 10.3201/eid2805.220197
Full text
Tu, TM et al. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore. JAMA Netw Open. 2022;5(3):e222940. DOI:10.1001/jamanetworkopen.2022.2940
Full text
Xie, Y and Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet, 21 March 21 2022, DOI: 10.1016/S2213-8587(22)00044-4
Full text
Yu, B et al. Accelerating PERx Reaction Enables Covalent Nanobodies for Potent Neutralization of SARS-Cov-2 and Variants. bioRxiv 14 March 2022, doi: 10.1101/2022.03.11.483867
Full text
Yu, J et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. March 16, 2022. DOI: 10.1056/NEJMc2201849
Full text
Wragg, KM et al, Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory. Nature Immunology, 21 March 2022. DOI: 10.1038/s41590-022-01175-5
Full text
Influenza and COVID-19
Su W, Wang H, Sun C, et al. The Association Between Previous Influenza Vaccination and Coronavirus Disease 2019 Infection Risk and Severity: A Systematic Review and Meta-Analysis [published online ahead of print, 2022 Mar 15]. Am J Prev Med. 2022, doi:10.1016/j.amepre.2022.02.008
Full text
January 2022
Akther T, Nur T. A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use. PLoS One. 2022;17(1):e0261869. Published 2022 Jan 12. doi:10.1371/journal.pone.0261869
Full text
Alu A, Chen L, Lei H, Wei Y, Tian X, Wei X. Intranasal COVID-19 vaccines: From bench to bed [published online ahead of print, 2022 Jan 24]. EBioMedicine. 2022;76:103841. doi:10.1016/j.ebiom.2022.103841
Full text
Andeobu L, Wibowo S, Grandhi S. Medical Waste from COVID-19 Pandemic-A Systematic Review of Management and Environmental Impacts in Australia. Int J Environ Res Public Health. 2022;19(3):1381. Published 2022 Jan 26. doi:10.3390/ijerph19031381
Full text
Atmar RL, Lyke KE, Deming ME, et al. Homologous and Heterologous Covid-19 Booster Vaccinations [published online ahead of print, 2022 Jan 26]. N Engl J Med. 2022;NEJMoa2116414. doi:10.1056/NEJMoa2116414
Full text
Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review [published online ahead of print, 2022 Jan 4]. Rev Endocr Metab Disord. 2022;1-21. doi:10.1007/s11154-021-09705-6
Full text
Balakrishnan V, Ng KS, Kaur W, Lee ZL. COVID-19 mental health prevalence and its risk factors in South East Asia [published online ahead of print, 2022 Jan 12]. Curr Psychol. 2022;1-16. doi:10.1007/s12144-021-02556-z
Full text
Bravo, Lulu et al. “Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.” Lancet (London, England) vol. 399,10323 (2022): 461-472. doi:10.1016/S0140-6736(22)00055-1
Full text
Chatterjee B, Thakur SS. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants. Expert Rev Vaccines. 2022;21(1):47-67. doi:10.1080/14760584.2022.1997601
Full text
Chen GL, Li XF, Dai XH, et al. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial [published online ahead of print, 2022 Jan 24]. Lancet Microbe. 2022;10.1016/S2666-5247(21)00280-9. doi:10.1016/S2666-5247(21)00280-9
Full text
Du Z, Wang L, Bai Y, et al. Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study. Lancet Reg Health Am. 2022;8:100182. doi:10.1016/j.lana.2021.100182
Full text
Enticott J, Gill JS, Bacon SL, et al. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open. 2022;12(1):e057127. Published 2022 Jan 3. doi:10.1136/bmjopen-2021-057127
Full text
Gruell H, Vanshylla K, Tober-Lau P, et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant [published online ahead of print, 2022 Jan 19]. Nat Med. 2022;1-4. doi:10.1038/s41591-021-01676-0
Full text
Haas JW, Bender FL, Ballou S, et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis [published correction appears in JAMA Netw Open. 2022 Feb 1;5(2):e221277]. JAMA Netw Open. 2022;5(1):e2143955. Published 2022 Jan 4. doi:10.1001/jamanetworkopen.2021.43955
Full text
Huang Z, Fu Z, Wang J. Review on drug regulatory science promoting COVID-19 vaccine development in china [published online ahead of print, 2022 Jan 21]. Engineering (Beijing). 2022;10.1016/j.eng.2022.01.001. doi:10.1016/j.eng.2022.01.001
Full text
Hwang YC, Lu RM, Su SC, et al. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci. 2022;29(1):1. Published 2022 Jan 4. doi:10.1186/s12929-021-00784-w
Full text
Israel A, Schäffer AA, Merzon E, et al. Predicting COVID-19 severity using major risk factors and received vaccines. Preprint. medRxiv. 2022;2021.12.31.21268575. Published 2022 Jan 3. doi:10.1101/2021.12.31.21268575
Full text
Jiang Y, Wu Q, Song P, You C. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines. Front Med (Lausanne). 2022;8:806641. Published 2022 Jan 18. doi:10.3389/fmed.2021.806641
Full text
Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol. 2022;12:821538. Published 2022 Jan 21. doi:10.3389/fimmu.2021.821538
Full text
Joshi R, Singla R, Mishra A, et al. A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines. New Microbes New Infect. 2022;45:100949. doi:10.1016/j.nmni.2022.100949
Full text
Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic [published online ahead of print, 2022 Jan 29]. Environ Res. 2022;209:112816. doi:10.1016/j.envres.2022.112816
Full text
Kim SH, Choi Y, Lee D, et al. Impact of COVID-19 on pregnant women in South Korea: Focusing on prevalence, severity, and clinical outcomes. J Infect Public Health. 2022;15(2):270-276. doi:10.1016/j.jiph.2022.01.004
Full text
Lally M. A cost-benefit analysis of COVID-19 lockdowns in Australia [published online ahead of print, 2022 Jan 28]. Monash Bioeth Rev. 2022;1-32. doi:10.1007/s40592-021-00148-y
Full text
Liao Q, Cowling BJ, Xiao J, et al. Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines. Vaccine. 2022;40(8):1074-1081. doi:10.1016/j.vaccine.2022.01.031
Full text
Liu H, Zhang J, Cai J, et al. Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. BMC Med. 2022;20(1):37. Published 2022 Jan 31. doi:10.1186/s12916-022-02243-1
Full text
Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health. 2022;15(2):228-240. doi:10.1016/j.jiph.2021.12.014
Full text
Masoudi M, Maasoumi R, Bragazzi NL. Effects of the COVID-19 pandemic on sexual functioning and activity: a systematic review and meta-analysis. BMC Public Health. 2022;22(1):189. Published 2022 Jan 28. doi:10.1186/s12889-021-12390-4
Full text
Mistry P, Barmania F, Mellet J, et al. SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front Immunol. 2022;12:809244. Published 2022 Jan 3. doi:10.3389/fimmu.2021.809244
Full text
Norhayati MN, Che Yusof R, Azman YM. Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance. Front Med (Lausanne). 2022;8:783982. Published 2022 Jan 27. doi:10.3389/fmed.2021.783982
Full text
Rahman S, Rahman MM, Miah M, et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci Rep. 2022;12(1):1438. Published 2022 Jan 26. doi:10.1038/s41598-022-05325-5
Full text
Rasmussen SA, Jamieson DJ. COVID-19 and Pregnancy [published online ahead of print, 2022 Jan 31]. Infect Dis Clin North Am. 2022;doi:10.1016/j.idc.2022.01.002
Full text
Ren SY, Wang WB, Gao RD, Zhou AM. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022;10(1):1-11. doi:10.12998/wjcc.v10.i1.1
Full text
Sekizawa Y, Hashimoto S, Denda K, Ochi S, So M. Association between COVID-19 vaccine hesitancy and generalized trust, depression, generalized anxiety, and fear of COVID-19. BMC Public Health. 2022;22(1):126. Published 2022 Jan 18. doi:10.1186/s12889-021-12479-w
Full text
Shakeel CS, Mujeeb AA, Mirza MS, Chaudhry B, Khan SJ. Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors. Vaccines (Basel). 2022;10(1):110. Published 2022 Jan 12. doi:10.3390/vaccines10010110
Full text
Stein M, Ashkenazi-Hoffnung L, Greenberg D, et al. The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines (Basel). 2022;10(1):81. Published 2022 Jan 6. doi:10.3390/vaccines10010081
Full text
Tazerji SS, Shahabinejad F, Tokasi M, et al. Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep. 2022;26:101505. doi:10.1016/j.genrep.2022.101505
Full text
Tian X, Bai Z, Cao Y, et al. Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19. Viruses. 2022;14(1):85. Published 2022 Jan 4. doi:10.3390/v14010085
Full text
Tsheten T, Tenzin P, Clements ACA, Gray DJ, Ugyel L, Wangdi K. The COVID-19 vaccination campaign in Bhutan: strategy and enablers. Infect Dis Poverty. 2022;11(1):6. Published 2022 Jan 5. doi:10.1186/s40249-021-00929-x
Full text
Wang X, Shi L, Zhang Y, et al. A Comparative Retrospective Study of COVID-19 Responses in Four Representative Asian Countries. Risk Manag Healthc Policy. 2022;15:13-25. Published 2022 Jan 11. doi:10.2147/RMHP.S334326
Full text
Yang W, Greene SK, Peterson ER, et al. Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant. Sci Adv. 2022;8(4):eabm0300. doi:10.1126/sciadv.abm0300
Full text
Zhang JJ, Dong X, Liu GH, Gao YD. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality [published online ahead of print, 2022 Jan 19]. Clin Rev Allergy Immunol. 2022;1-18. doi:10.1007/s12016-022-08921-5
Full text
Zhang M, Liang Y, Yu D, et al. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Int J Biol Sci. 2022;18(2):889-900. Published 2022 Jan 1. doi:10.7150/ijbs.68973
Full text
Influenza and COVID-19
Akaba H, Jindai K, Shobugawa Y, Oshitani H. Incidence and length of outbreak period of COVID-19 and population density in comparison with seasonal influenza in Japan. IJID Regions. 2022;2:154-157. doi:10.1016/j.ijregi.2022.01.003
Full text
Heithoff DM, Barnes L 5th, Mahan SP, et al. Assessment of a Smartphone-Based Loop-Mediated Isothermal Amplification Assay for Detection of SARS-CoV-2 and Influenza Viruses. JAMA Netw Open. 2022;5(1):e2145669. Published 2022 Jan 4. doi:10.1001/jamanetworkopen.2021.45669
Full text
Taniguchi Y, Kuno T, Komiyama J, et al. Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan. Lancet Reg Health West Pac. 2022;20:100365. doi:10.1016/j.lanwpc.2021.100365
Full text
(Updated 1 July 2022)